LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Publisher: European Respiratory Society
Languages: English
Types: Article
Subjects:
Introduction: As idiopathic pulmonary fibrosis emerges as an important public health problem, there is a need to coordinate data on incidence and mortality globally. This study aims to systematically assess all available studies to investigate the global burden of disease. \ud \ud Methods: Medline and Embase databases were searched systematically for all population-based studies of incidence or mortality of idiopathic pulmonary fibrosis. Clinical case series and prevalence studies were excluded. The search was supplemented using Google search engine, hand-searching of references and conference abstracts. Data were extracted independently by two authors using a pre-specified proforma, with assessment of methodological quality.\ud \ud Results: 34 studies were identified providing data from 21 countries from 1968-2012. 28 studies reported incidence data, and eight reported mortality data. In studies from year 2000 onwards, we estimated a conservative incidence range of 3-9 cases per 100,000 per year for Europe and North America. Incidence was lower in East Asia and South America. The majority of studies showed an increase in incidence over time. \ud \ud Conclusions: The incidence of idiopathic pulmonary fibrosis is increasing worldwide, and rates are coming together across countries. Current data suggest incidence is similar to that of conditions such as stomach, liver, testicular and cervical cancers.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Navaratnam V, Fleming KM, West J, Smith CJ, Jenkins RG, Fogarty A, Hubbard RB. The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax 2011; 66: 462-467.
    • 2. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. American Journal of Respiratory & Critical Care Medicine 2006; 174: 810- 816.
    • 3. Lai CC, Wang CY, Lu HM, Chen L, Teng NC, Yan YH, Wang JY, Chang YT, Chao TT, Lin HI, Chen CR, Yu CJ, Wang JD. Idiopathic pulmonary fibrosis in Taiwan - A population-based study. Respiratory Medicine 2012; 106: 1566-1574.
    • 4. Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respira Rev 2012; 21: 355-361.
    • 5. Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol 2013; 25: 483-492.
    • 6. Kaunisto J, Salomaa ER, Hodgson U, Kaarteenaho R, Myllarniemi M. Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data. BMC Pulm Med 2013; 13.
    • 7. Annesi-Maesano I, Nunes H, Duchemann B, Valeyre D, Agabiti N, Saltini C, Porretta MA. Epidemiology of idiopathic pulmonary fibrosis in Europe - an update. Sarcoidosis Vasculitis & Diffuse Lung Diseases 2013; 30: 6-12.
    • 8. Demedts M, Wells AU, Anto JM, Costabel U, Hubbard R, Cullinan P, Slabbynck H, Rizzato GP, V., Verbeken EK, Thomeer MJ, Kokkarinen J, Dalphin JC, Newman Taylor AJ. Interstitial lung diseases: an epidemiolgical overview. Eur Respir J 2001; 18: 2s-16s.
    • 9. Hutchinson JP, McKeever TM, Fogarty AW, Navaratnam V, Hubbard RB. Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century. Annals of the American Thoracic Society 2014; 11: 1176-1185.
    • 10. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. British Journal of Dermatology 2012; 166: 1069-1080.
    • 11. Shamliyan TA, Kane RL, Ansari MT, Raman G, Berkman ND, Grant M, Janes G, Maglione M, Moher D, Nasser M, Robinson KA, Segal JB, Tsouros S. Development of Quality Criteria to Evaluate Nontherapeutic Studies of Incidence, Prevalence, or Risk Factors of Chronic Diseases: Pilot Study of New Checklists. Rockville (MD): Agency for Healthcare Research Quality (US); 2011.
    • 12. Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JLHR. Prevalence of erectile dysfunction: a systematic review of population-based studies. International Journal of Impotence Research 2002; 14: 422-432.
    • 13. Porretta MA, Bauleo L, Coppola A, Sergiacomi G, Zappa S, Carlone S, Mariotta S, Palange P, Valente S, Pezzuto G, Agabiti N, Pallante M, Puxeddu E, Saltini C. Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region. ERS Annual Congress; 2013.
    • 14. Agabiti N, Porretta MA, Bauleo L, Coppola A, Sergiacomi G, Fusco A, Cavalli F, Zappa MC, Vignarola R, Carlone S, Facchini G, Mariotta S, Palange P, Valente S, Pasciuto G, Pezzuto G, Orlandi A, Fusco D, Davoli M, Saltini C, Puxeddu E. Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2014; 31: 191-197.
    • 15. Hubbard R, Johnston I, Coultas DB, Britton J. Mortality rates from cryptogenic fibrosing alveolitis in seven countries. Thorax 1996; 51: 711-716.
    • 16. Mannino DM, Etzel RA, Gibson Parrish R. Pulmonary fibrosis deaths in the United States, 1979- 1991: An analysis of multiple-cause mortality data. American Journal of Respiratory and Critical Care Medicine 1996; 153: 1548-1552.
    • 17. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. American Journal of Respiratory & Critical Care Medicine 2007; 176: 277-284.
    • 18. Pinheiro GA, Antao VC, Wood JM, Wassell JT. Occupational risks for idiopathic pulmonary fibrosis mortality in the United States. International Journal of Occupational and Environmental Health 2008; 14: 117-123.
    • 19. Rufino RL, Costa CHD, Accar J, Torres GR, Silva VL, Barros NP, Graca NP. Incidence and Mortality of Interstitial Pulmonary Fibrosis in Brazil. ATS: Am J Respir Crit Care Med; 2013. p. A1458.
    • 20. Fortuna FP, Perin C, Cunha L, Moreira JS, Rubin AS. Mortality caused by idiopathic pulmonary fibrosis in the state of Rio Grande do Sul (Brazil). J Pneumologia 2003; 29: 121-124.
    • 21. Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61: 980-985.
    • 22. Maher TM, Strongman H, Boggon R, Kausar I. Idiopathic pulmonary fibrosis survival has not improved in the 21st century; Analysis of CPRD GOLD primary care data. BTS: Thorax; 2013. p. A82.
    • 23. Kornum JB, Christensen S, Grijota M, Pedersen L, Wogelius P, Beiderbeck A, Sorensen HT. The incidence of interstitial lung disease 1995-2005: a Danish nationwide population-based study. BMC Pulmonary Medicine 2008; 8: 24.
    • 24. Han S, Mok Y, Jee SH, S.K. D. Incidence and Mortality of Idiopathic Pulmonary Fibrosis in South Korea. ATS: Am J Respir Crit Care Med; 2013.
    • 25. Munakata M, Asakawa M, Hamma Y, Kawakami Y. Present status of idiopathic interstitial pneumonia--from epidemiology to etiology. Nihon Kyobu Shikkan Gakkai Zasshi Japanese Journal of Thoracic Diseases 1994; 32: 187-192.
    • 26. Ohno S, Nakaya T, Bando M, Sugiyama Y. Idiopathic pulmonary fibrosis - results from a Japanese nationwide epidemiological survey using individual clinical records. Respirology 2008; 13: 926-928.
    • 27. Ehrlich SF, Quesenberry Jr CP, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010; 33: 55-60.
    • 28. Saad N, Camus P, Suissa S, Ernst P. Statins and the risk of interstitial lung disease: a cohort study. Thorax 2013; 68: 361-364.
    • 29. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. American Journal of Respiratory & Critical Care Medicine 1994; 150: 967-972.
    • 30. Fernandez Perez ER, Daniels CE, Schroeder DR, St Sauver J, Hartman TE, Bartholmai BJ, Yi ES, Ryu JH. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a populationbased study. Chest 2010; 137: 129-137.
    • 31. Duchemann B, Annesi-Maesano I, Naurois CJD, Liote H, Neuville M, Naccache J-M, Borie R, Mekinian A, Mathieu M, Crestani B, Cadranel J, Fain O, Valeyre D, Nunes H. Prevalence and Incidence of Interstitial Lung Diseases in a French Multi-Ethnic County. ATS: Am J Respir Crit Care Med; 2013. p. A1459.
    • 32. Szafranski W. Interstitial lung diseases among patients hospitalized in the Department of Respiratory Medicine in Radom District Hospital during the years 2000-2009. Pneumonologia Alergol Pol 2012; 80: 523-532.
    • 33. von Plessen C, Grinde O, Gulsvik A. Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. Respiratory Medicine 2003; 97: 428-435.
    • 34. Kolek V. Epidemiology of cryptogenic fibrosing alveolitis in Moravia and Silesia. Acta Universitatis Palackianae Olomucensis Facultatis Medicae 1994; 137: 49-50.
    • 35. Liebetrau G, Mader I, Treutler D, Wiesner C. Epidemiologic aspects of different forms of alveolitis and lung fibrosis. [German]. Zur Epidemiologie Von Alveolitiden Und Lungenfibrosen. Allergologie 1992; 15: 15-20.
    • 36. Karakatsani A, Papakosta D, Rapti A, Antoniou KM, Dimadi M, Markopoulou A, Latsi P, Polychronopoulos V, Birba G, Ch L, Bouros D. Epidemiology of interstitial lung diseases in Greece. Respir Med 2009; 103: 1122-1129.
    • 37. Musellim B, Okumus G, Uzaslan E, Akgun M, Cetinkaya E, Turan O, Akkoclu A, Hazar A, Kokturk N, Calisir HC, Group TILD. Epidemiology and distribution of interstitial lung diseases in Turkey. Clin Respir J 2013; 8: 55-62.
    • 38. Lopez-Campos JL, Rodriguez-Becerra E, Neumosur Task G, Registry of Interstitial Lung D. Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study. European Journal of Epidemiology 2004; 19: 155-161.
    • 39. Xaubet A, Ancochea J, Morell F, Rodriguez-Arias JM, Villena V, Blanquer R, Montero C, Sueiro A, Disdier C, Vendrell M. Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2004; 21: 64-70.
    • 40. Tinelli C, De Silvestri A, Richeldi L, Oggionni T. The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report. Sarcoidosis Vasculitis & Diffuse Lung Diseases 2005; 22 Suppl 1: S4-8.
    • 41. Thomeer M, Demedts M, Vandeurzen K. Registration of interstitial lung diseases by 20 centres of respiratory medicine in flanders. Acta Clinica Belgica 2001; 56: 163-172.
    • 42. Hyldgaard C, Hilberg O, Muller A, Bendstrup E. A cohort study of interstitial lung diseases in central Denmark. Respir Med 2014; 108: 793-799.
    • 43. Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, Collard HR. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001- 11. The lancet Respiratory medicine 2014.
    • 44. American Thoracic Society, European Respiratory Society. American Thoracic Society / European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
    • 45. Travis WD, Costabel U, Hansell DM, King TE, Jr., Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748.
    • 46. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
    • 47. Cancer Research UK. UK Cancer Incidence (2011) by Country Summary. January 2014, 2 Sept 2014]. Available from: http://publications.cancerresearchuk.org/cancerstats/statsincidence/dtinccountries.html.
    • 48. NAACCR-FastStats. NAACCR Fast Stats: An interactive tool for quick access to key NAACCR cancer statistics. North American Association of Central Cancer Registries. 2 Sept 2014]. Available from: http://faststats.naaccr.org/.
    • 49. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Jr., Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article